Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice

Molecular Endocrinology

Volumn 26, Issue 5, 2012, Pages 809-818

  Ueta, Cintia B ^a   Oskouei, Behzad N ^a   Olivares, Emerson L ^a   Pinto, Jose R ^a   Correa, Mayrin M ^a   Simovic, Gordana ^a   Simonides, Warner S ^b   Hare, Joshua M ^a   Bianco, Antonio C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; OXIDOREDUCTASE; THYROID HORMONE; THYROID HORMONE INACTIVATING DEIODINASE 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ENZYME ACTIVITY; ENZYME INACTIVATION; EXPERIMENTAL MODEL; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART VENTRICLE REMODELING; KNOCKOUT MOUSE; MALE; MORTALITY; MOUSE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTIVE CARDIOMYOPATHY; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALIA; MUS;

EID: 84860331721     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1325     Document Type: Article

References (27)

1. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeöld A, Bianco AC 2008 Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29: 898-938
2. Galton VA 2005 The roles of the iodothyronine deiodinases in mammalian development. Thyroid 15:823-834
3. Hall JA, Ribich S, Christoffolete MA, Simovic G, Correa-Medina M, Patti ME, Bianco AC 2010 Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis. Endocrinology 151:4573-4582
4. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G 2003 Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202-3211
5. Huang SA, Bianco AC 2008 Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pract Endocrinol Metab 4:148-155
6. Wassen FW, Schiel AE, Kuiper GG, Kaptein E, Bakker O, Visser TJ, Simonides WS 2002 Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 143: 2812-2815
7. Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, Wassen FW, Crescenzi A, da-Silva WS, Harney J, Engel FB, Obregon MJ, Larsen PR, Bianco AC, Huang SA 2008 Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest 118:975-983
8. Olivares EL, Marassi MP, Fortunato RS, da Silva AC, Costa-e- Sousa RH, Araújo IG, Mattos EC, Masuda MO, Mulcahey MA, Huang SA, Bianco AC, Carvalho DP 2007 Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology 148: 4786-4792
9. Pol CJ, Muller A, Zuidwijk MJ, van Deel ED, Kaptein E, Saba A, Marchini M, Zucchi R, Visser TJ, Paulus WJ, Duncker DJ, Simonides WS 2011 Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology 152:669-679
10. Freitas BC, Gereben B, Castillo M, Kalló I, Zeöld A, Egri P, Liposits Z, Zavacki AM, Maciel RM, Jo S, Singru P, Sanchez E, Lechan RM, Bianco AC 2010 Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest 120:2206-2217
11. da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC 2008 Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet 24:306-316
12. Hagan JP, O'Neill BL, Stewart CL, Kozlov SV, Croce CM 2009 At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1. PLoS One 4:e4352
13. Simonides WS, van Hardeveld C 2008 Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid 18:205-216
14. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
15. Sandler G, Wilson GM 1959 The production of cardiac hypertrophy by thyroxine in the rat. Q J Exp Physiol Cogn Med Sci 44:282-289
16. Sandler G, Wilson GM 1959 The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. Q J Med 28:347-369
17. Brooks WW, Conrad CH 2009 Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. Comp Med 59:339-343
18. Martins MR, Doin FC, Komatsu WR, Barros-Neto TL, Moises VA, Abucham J 2007 Growth hormone replacement improves thyroxine biological effects: implications for management of central hypothyroidism. J Clin Endocrinol Metab 92:4144-4153
19. Willott RH, Gomes AV, Chang AN, Parvatiyar MS, Pinto JR, Potter JD 2010 Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? J Mol Cell Cardiol 48:882-892
20. Drazner MH 2011 The progression of hypertensive heart disease. Circulation 123:327-334
21. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC 2001 Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89:591-598
22. Trivieri MG, Oudit GY, Sah R, Kerfant BG, Sun H, Gramolini AO, Pan Y, Wickenden AD, Croteau W, Morreale de Escobar G, Pekhletski R, St Germain D, Maclennan DH, Backx PH 2006 Cardiacspecific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci USA 103:6043-6048
23. Carvalho-Bianco SD, Kim BW, Zhang JX, Harney JW, Ribeiro RS, Gereben B, Bianco AC, Mende U, Larsen PR 2004 Chronic cardiacspecific thyrotoxicosis increases myocardial β-adrenergic responsiveness. Mol Endocrinol 18:1840-1849
24. Oliveira JH, Persani L, Beck-Peccoz P, Abucham J 2001 Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. J Clin Endocrinol Metab 86: 1694-1699
25. Hernandez A, Martinez ME, Fiering S, Galton VA, St Germain D 2006 Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest 116:476-484
26. Castillo M, Hall JA, Correa-Medina M, Ueta C, Kang HW, Cohen DE, Bianco AC 2011 Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes 60: 1082-1089
27. Baudenbacher F, Schober T, Pinto JR, Sidorov VY, Hilliard F, Solaro RJ, Potter JD, Knollmann BC 2008 Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest 118:3893-3903